Combinative treatment of Curdione and docetaxel triggers reactive oxygen species (ROS)-mediated intrinsic apoptosis of triple-negative breast cancer cells

Bioengineered. 2021 Dec;12(2):10037-10048. doi: 10.1080/21655979.2021.1994737.

Abstract

TNBC: triple negative breast cancer; ROS: reactive oxygen species; NAC: N-acetyl-L-cysteine; DTX: docetaxel; MAPKs: mitogen-actived protein kinases; PI3K/Akt: phosphatidylinositol 3-kinases (PI3K) /Akt; NF-Κb: the nuclear factor κB (NF-κB).

Keywords: Curdione; chemo-sensitization; docetaxel; reactive oxygen species (ROS); triple-negative breast cancer (TNBC).

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Apoptosis* / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Docetaxel / pharmacology*
  • Humans
  • Mitogen-Activated Protein Kinases / metabolism
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Reactive Oxygen Species / metabolism*
  • Sesquiterpenes, Germacrane / pharmacology*
  • Signal Transduction / drug effects
  • Triple Negative Breast Neoplasms / pathology*

Substances

  • Reactive Oxygen Species
  • Sesquiterpenes, Germacrane
  • curdione
  • Docetaxel
  • Proto-Oncogene Proteins c-akt
  • Mitogen-Activated Protein Kinases

Grants and funding

The author(s) reported there is no funding associated with the work featured in this article.